Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Hilgeroth

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Medicinal Chemistry (Shariqah (United Arab Emirates))|August 17, 2012
A tribute to a living legendWilliam J Hoekstra, Andreas Hilgeroth, Kuo-Chen Chou, et al.
Bioorganic & Medicinal Chemistry|October 4, 2011
Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationshipsSören Krawczyk, Monika Otto, Alexander Otto, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 15, 2015
Novel inhibitors of the methicillin-resistant Staphylococcus aureus (MRSA)-pyruvate kinaseMardia Telep El-Sayed, Roya Zoraghi, Neil Reiner, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 22, 2012
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluationAndreas Hilgeroth, Christiane Baumert, Claudius Coburger, et al.
Future Medicinal Chemistry|June 10, 2020
Novel effective antibacterial small-molecules against <i>Staphylococcus</i> and <i>Enterococcus</i> strainsKaveh Yasrebi, Nico Schade, Emmanuel Tola Adeniyi, et al.
Molecules (Basel, Switzerland)|September 15, 2018
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation AssayMax Holzer, Nico Schade, Ansgar Opitz, et al.
European Journal of Medicinal Chemistry|February 8, 2005
The interaction between resistance modifiers such as pyrido[3,2-g]quinoline, aza-oxafluorene and pregnane derivatives with DNA, plasmid DNA and tRNADerek Sharples, Gabriella Spengler, Joseph Molnár, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Medicinal Chemistry (Shariqah (United Arab Emirates))|August 17, 2012
A tribute to a living legendWilliam J Hoekstra, Andreas Hilgeroth, Kuo-Chen Chou, et al.
Bioorganic & Medicinal Chemistry|October 4, 2011
Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationshipsSören Krawczyk, Monika Otto, Alexander Otto, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 15, 2015
Novel inhibitors of the methicillin-resistant Staphylococcus aureus (MRSA)-pyruvate kinaseMardia Telep El-Sayed, Roya Zoraghi, Neil Reiner, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|November 22, 2012
Novel structurally varied N-alkyl 1,4-dihydropyridines as ABCB1 inhibitors: structure-activity relationships, biological activity and first bioanalytical evaluationAndreas Hilgeroth, Christiane Baumert, Claudius Coburger, et al.
Future Medicinal Chemistry|June 10, 2020
Novel effective antibacterial small-molecules against <i>Staphylococcus</i> and <i>Enterococcus</i> strainsKaveh Yasrebi, Nico Schade, Emmanuel Tola Adeniyi, et al.
Molecules (Basel, Switzerland)|September 15, 2018
Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation AssayMax Holzer, Nico Schade, Ansgar Opitz, et al.
European Journal of Medicinal Chemistry|February 8, 2005
The interaction between resistance modifiers such as pyrido[3,2-g]quinoline, aza-oxafluorene and pregnane derivatives with DNA, plasmid DNA and tRNADerek Sharples, Gabriella Spengler, Joseph Molnár, et al.
Pageof 7